JP2011518787A5 - - Google Patents

Download PDF

Info

Publication number
JP2011518787A5
JP2011518787A5 JP2011505218A JP2011505218A JP2011518787A5 JP 2011518787 A5 JP2011518787 A5 JP 2011518787A5 JP 2011505218 A JP2011505218 A JP 2011505218A JP 2011505218 A JP2011505218 A JP 2011505218A JP 2011518787 A5 JP2011518787 A5 JP 2011518787A5
Authority
JP
Japan
Prior art keywords
clonidine
pharmaceutical composition
composition according
target tissue
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011505218A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011518787A (ja
Filing date
Publication date
Priority claimed from US12/408,491 external-priority patent/US20090263443A1/en
Application filed filed Critical
Publication of JP2011518787A publication Critical patent/JP2011518787A/ja
Publication of JP2011518787A5 publication Critical patent/JP2011518787A5/ja
Pending legal-status Critical Current

Links

JP2011505218A 2008-04-18 2009-04-17 痙直及び振戦のような術後作用をクロニジンで治療する方法 Pending JP2011518787A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US4619208P 2008-04-18 2008-04-18
US61/046,192 2008-04-18
US12/408,491 US20090263443A1 (en) 2008-04-18 2009-03-20 Methods for treating post-operative effects such as spasticity and shivering with clondine
US12/408,491 2009-03-20
PCT/US2009/040885 WO2009129428A2 (en) 2008-04-18 2009-04-17 Methods for treating post-operative effects such as spasticity and shivering with clonidine

Publications (2)

Publication Number Publication Date
JP2011518787A JP2011518787A (ja) 2011-06-30
JP2011518787A5 true JP2011518787A5 (enExample) 2012-01-19

Family

ID=41199746

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011505218A Pending JP2011518787A (ja) 2008-04-18 2009-04-17 痙直及び振戦のような術後作用をクロニジンで治療する方法

Country Status (5)

Country Link
US (1) US20090263443A1 (enExample)
EP (1) EP2207545B1 (enExample)
JP (1) JP2011518787A (enExample)
CN (1) CN101827592A (enExample)
WO (1) WO2009129428A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE48948E1 (en) 2008-04-18 2022-03-01 Warsaw Orthopedic, Inc. Clonidine compounds in a biodegradable polymer
US20100239632A1 (en) 2009-03-23 2010-09-23 Warsaw Orthopedic, Inc. Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue
WO2012075447A2 (en) * 2010-12-03 2012-06-07 Warsaw Orthopedic, Inc. Compositions and methods for delivering clonidine and bupivacaine to a target tissue site
WO2012075451A2 (en) 2010-12-03 2012-06-07 Warsaw Orthopedic, Inc. Clonidine and gaba compounds in a biodegradable polymer carrier
GB201505527D0 (en) 2015-03-31 2015-05-13 Jmedtech Pte Ltd Composition
US20170079985A1 (en) * 2015-09-21 2017-03-23 Teva Pharmaceuticals International Gmbh Sustained release olanzapine formulations
EP3600258A1 (en) 2017-03-20 2020-02-05 Teva Pharmaceuticals International GmbH Sustained release olanzapine formulaitons
EP3691618A1 (en) 2017-10-06 2020-08-12 Foundry Therapeutics, Inc. Implantable depots for the controlled release of therapeutic agents
CN116650732A (zh) 2018-01-08 2023-08-29 铸造疗法股份有限公司 经由治疗剂的控制递送用于治疗腔内癌症的装置、系统和方法
US12458589B2 (en) 2018-05-12 2025-11-04 Foundry Therapeutics, Inc. Implantable polymer depots for the controlled release of therapeutic agents
EP3843710A1 (en) 2018-08-28 2021-07-07 Foundry Therapeutics, Inc. Polymer implants

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1248450A (en) * 1984-04-05 1989-01-10 Kazuo Kigasawa Soft patch
US5942241A (en) * 1995-06-09 1999-08-24 Euro-Celtique, S.A. Formulations and methods for providing prolonged local anesthesia
US6113624A (en) * 1995-10-02 2000-09-05 Ethicon, Inc. Absorbable elastomeric polymer
ATE318580T1 (de) * 1996-12-20 2006-03-15 Alza Corp Gelzusammensetzungen und verfahren
US6294170B1 (en) * 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
TW577758B (en) * 1997-10-27 2004-03-01 Ssp Co Ltd Intra-articular preparation for the treatment of arthropathy
EP1077653B1 (en) * 1998-05-12 2004-03-31 Boston Scientific Limited Manual bone anchor placement devices
US6632457B1 (en) * 1998-08-14 2003-10-14 Incept Llc Composite hydrogel drug delivery systems
US6927044B2 (en) * 1998-09-25 2005-08-09 Regeneron Pharmaceuticals, Inc. IL-1 receptor based cytokine traps
US6143314A (en) * 1998-10-28 2000-11-07 Atrix Laboratories, Inc. Controlled release liquid delivery compositions with low initial drug burst
US6565874B1 (en) * 1998-10-28 2003-05-20 Atrix Laboratories Polymeric delivery formulations of leuprolide with improved efficacy
US6436099B1 (en) * 1999-04-23 2002-08-20 Sdgi Holdings, Inc. Adjustable spinal tether
US7220281B2 (en) * 1999-08-18 2007-05-22 Intrinsic Therapeutics, Inc. Implant for reinforcing and annulus fibrosis
US7329529B2 (en) * 1999-09-03 2008-02-12 Millennium Pharmaceuticals, Inc. Ubiqutin proteases
US7951201B2 (en) * 1999-10-20 2011-05-31 Anulex Technologies, Inc. Method and apparatus for the treatment of the intervertebral disc annulus
US6461631B1 (en) * 1999-11-16 2002-10-08 Atrix Laboratories, Inc. Biodegradable polymer composition
DK1244388T3 (da) * 1999-12-06 2007-05-14 Warsaw Orthopedic Inc Indretning til behandling af mellemhvirvelskiver
US6589549B2 (en) * 2000-04-27 2003-07-08 Macromed, Incorporated Bioactive agent delivering system comprised of microparticles within a biodegradable to improve release profiles
DE60137542D1 (de) * 2001-01-03 2009-03-12 Bausch & Lomb Wirkstoffabgabevorrichtungen mit verzögerter freisetzung mehrere stoffe enthaltend
US7229441B2 (en) * 2001-02-28 2007-06-12 Warsaw Orthopedic, Inc. Flexible systems for spinal stabilization and fixation
US7235043B2 (en) * 2001-03-09 2007-06-26 Boston Scientific Scimed Inc. System for implanting an implant and method thereof
MXPA01011542A (es) * 2001-11-13 2003-05-22 Alcon Inc Regeneracion del cartilago articular da°ado por la osteoartritis de grado i y ii, mediante la aplicacion intra-articular de una mezcla de hialuronato de sodio y de condroitin sulfato en un vehiculo de gel.
US6974462B2 (en) * 2001-12-19 2005-12-13 Boston Scientific Scimed, Inc. Surgical anchor implantation device
US8133501B2 (en) * 2002-02-08 2012-03-13 Boston Scientific Scimed, Inc. Implantable or insertable medical devices for controlled drug delivery
US7345065B2 (en) * 2002-05-21 2008-03-18 Allergan, Inc. Methods and compositions for alleviating pain
US20040109893A1 (en) * 2002-06-25 2004-06-10 Guohua Chen Sustained release dosage forms of anesthetics for pain management
EP1531757B1 (en) * 2002-07-19 2016-09-07 Omeros Corporation Biodegradable triblock copolymers, synthesis methods therefor, and hydrogels and biomaterials made there from
US20040166088A1 (en) * 2003-01-15 2004-08-26 Shalaby Shalaby W. Polymeric precursors of non-absorbable, in situ-forming hydrogels and applications thereof
US20050079202A1 (en) * 2003-05-30 2005-04-14 Guohua Chen Implantable elastomeric depot compositions and uses thereof
US7144412B2 (en) * 2003-06-25 2006-12-05 Wolf Medical Enterprises, Inc. Gold suture and method of use in wound closure
US20050058696A1 (en) * 2003-09-12 2005-03-17 Allergan, Inc. Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions
US20050059744A1 (en) * 2003-09-12 2005-03-17 Allergan, Inc. Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions
WO2005046746A2 (en) * 2003-11-10 2005-05-26 Angiotech International Ag Medical implants and fibrosis-inducing agents
US20050175709A1 (en) * 2003-12-11 2005-08-11 Baty Ace M.Iii Therapeutic microparticles
JP2007519756A (ja) * 2004-01-30 2007-07-19 アンジオテック インターナショナル アーゲー 拘縮を治療するための組成物および方法
US7361168B2 (en) * 2004-04-21 2008-04-22 Acclarent, Inc. Implantable device and methods for delivering drugs and other substances to treat sinusitis and other disorders
US7410480B2 (en) * 2004-04-21 2008-08-12 Acclarent, Inc. Devices and methods for delivering therapeutic substances for the treatment of sinusitis and other disorders
US8741332B2 (en) * 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for dermally treating neuropathic pain
US8512730B2 (en) * 2004-07-12 2013-08-20 Isto Technologies, Inc. Methods of tissue repair and compositions therefor
US20060046961A1 (en) * 2004-09-02 2006-03-02 Mckay William F Controlled and directed local delivery of anti-inflammatory compositions
US20060074422A1 (en) * 2004-09-27 2006-04-06 Story Brooks J Suture anchor and void filler combination
US20060253100A1 (en) * 2004-10-22 2006-11-09 Medtronic, Inc. Systems and Methods to Treat Pain Locally
CN101119713A (zh) * 2004-11-24 2008-02-06 阿尔高克斯制药公司 类辣椒素凝胶制剂及其用途
US7611494B2 (en) * 2005-02-08 2009-11-03 Confluent Surgical, Inc. Spray for fluent materials
US20060183786A1 (en) * 2005-02-16 2006-08-17 Chi Mei Foundation Hospital Injectable long-acting analgesic composition comprising an ester derivative of ketorolac
EP1881821B1 (en) * 2005-05-20 2016-11-09 Omeros Corporation Compositions comprising ketoprofen and calcium channel antagonist for use in urological procedures
US7610100B2 (en) * 2005-12-30 2009-10-27 Boston Scientific Neuromodulation Corporation Methods and systems for treating osteoarthritis
US7741273B2 (en) * 2006-04-13 2010-06-22 Warsaw Orthopedic, Inc. Drug depot implant designs
US20070253994A1 (en) * 2006-04-28 2007-11-01 Medtronic, Inc. Intraspinal Drug Delivery Methods and Devices To Alleviate Chronic Pelvic Pain
WO2008003093A2 (en) * 2006-06-29 2008-01-03 Questcor Pharmaceuticals, Inc. Pharmaceutical compositions and related methods of treatment
US20100040609A1 (en) * 2006-07-07 2010-02-18 Gorman James R Methods for preventing, postponing or improving the outcome of invasive spinal procedures
US20080091207A1 (en) * 2006-10-13 2008-04-17 Csaba Truckai Bone treatment systems and methods

Similar Documents

Publication Publication Date Title
EP2032128B1 (en) Use of substituted 2-aminotetralines for the manufacture of a medicament for the prevention, alleviation and/or treatment of various types of pain
WO2009129509A3 (en) Methods and compositions for treating post-operative pain comprising a local anesthetic
Kim et al. Dexamathasone added to levobupivacaine improves postoperative analgesia in ultrasound guided interscalene brachial plexus blockade for arthroscopic shoulder surgery
US12109181B2 (en) Lidocaine patch and methods of use thereof
WO2009129437A3 (en) Methods and compositions for treating post-operative pain comprising clonidine
JP2009542702A5 (enExample)
JP2009542699A5 (enExample)
WO2012007159A3 (en) Novel gastro-retentive dosage forms
WO2010011526A3 (en) Drug depots having one or more anchoring members
WO2009129210A4 (en) Compositions and methods for treating post-operative pain using clonidine and bupivacaine
MX2012000275A (es) Antagonista de bomba de acido para el tratamiento de enfermedades involucradas en la motilidad gastrointestinal anormal.
WO2010009116A3 (en) Methods and compositions for treating postoperative pain comprising nonsteroidal anti-inflammatory agents
EA201270144A1 (ru) Комбинированная терапия при лечении диабета
WO2012012347A3 (en) Methods of intravenous administration of glyburide and other drugs
JP2008520544A5 (ja) 癌関連疲労の治療または予防のための医薬の製造への使用方法
ES2704987T3 (es) Composiciones farmacéuticas para terapia de combinación
RU2015103107A (ru) Комбинированная композиция
JP2011503212A5 (enExample)
JP2014139255A5 (enExample)
Sivrikaya Multimodal analgesia for postoperative pain management
GB2435211B (en) Drug delivery system
IL273715B2 (en) Subcutaneous biodegradable naltrexone implant and accompanying behavioral program for weight loss in a patient
RU2013157834A (ru) Композиции для подкожного введения физиологически активных средств
US20190381061A1 (en) Local anesthesia pain-relieving time-delay agent
RU2010146309A (ru) Фармацевтическая композиция для лечения фибромиалгии